Buspirone Hydrochloride
Specifications
33386-08-2CAS Number
251-489-4EC Number
8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochlorideIUPAC Name
C21H32ClN5O2Chemical Formula
422 g/molMolecular Weight
Buspirone hydrochloride; 33386-08-2; Buspirone HCL; Spamilan; MJ 9022-1; NSC-751138; NSC-759571; 207LT9J9OC; APD405; MJ-9022-1; APD-405; N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1,1-cyclopentanediacetamide monohydrochloride; CHEBI:3224; DTXSID1037193; 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride; 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride; 8-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione hydrochloride; N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-1,1-cyclopentanediacetamide monohydrochloride; 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, monohydrochloride; Hydrochloride, Buspirone; RefChem:57603; DTXCID9017193; MJ90221; MJ 9022 1; 251-489-4; Buspar; Narol; Buspimen; Buspirone (hydrochloride); 8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione hydrochloride; MFCD00078569; 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride; MLS000069796; Buspirone.HCl; 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione; 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione hydrochloride; Ansitec; Anxinil; Anxiolan; Busirone; Buspinol; Censpar; Effiplen; Establix; Kallmiren; Lucelan; Mabuson; Normaton; SMR000058186; Barpil; Itagil; Nerbet; Sburol; Travin; Tutran; Biron; Relac; Apo-Buspirone; Ansiced; C21H32ClN5O2; Buspirone hydrochloride [USAN]; SR-01000075541; EINECS 251-489-4; UNII-207LT9J9OC; Prestwick_711; Buspirone hydrochloride [USAN:USP]; Buspar (TN); Opera_ID_707; 33386-08-2 (HCl); Buspirone hydrochloride CRS; 1,1-Cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, hydrochloride; 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione hydrochloride; N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride; Buspirone hydrochloride[JAN]; SCHEMBL41495; MLS001076085; MLS002548862; Buspirone hydrochloride (USP); orb1225273; orb1306402; orb3141385; CHEMBL1200399; HY-B1115R; MSK10309A; HMS1569I19; HMS3750O03; HMS5082F20; HMS6019A05; Pharmakon1600-02300173; Buspirone HCl - Bio-X trade mark; APC-6002; APC-6003; HY-B1115; BUSPIRONE HYDROCHLORIDE [MI]; Tox21_500223; Buspirone (hydrochloride) (Standard); Buspirone for system suitability CRS; EBC-14142; HB1649; NSC751138; NSC759571; s4256; AKOS015962019; AC-1905; BUSPIRONE HYDROCHLORIDE [MART.]; BUSPIRONE HYDROCHLORIDE [VANDF]; CCG-213652; CS-4714; FB38586; FP19364; KS-5163; LP00223; NC00673; NSC 751138; NSC 759571; 1,1-Cyclopentanediacetimide, N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride; BUSPIRONE HYDROCHLORIDE [USP-RS]; BUSPIRONE HYDROCHLORIDE [WHO-DD]; NCGC00093692-01; NCGC00093692-02; NCGC00260908-01; 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione monohydrochloride; 8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, monohydrochloride; B8274; BUSPIRONE HYDROCHLORIDE [ORANGE BOOK]; EU-0100223; NS00076188; ST51014924; SW155073-5; T2132; BUSPIRONE HYDROCHLORIDE [EP MONOGRAPH]; B 7148; BUSPIRONE HYDROCHLORIDE [USP MONOGRAPH]; D00702; D96810; EN300-122362; Buspirone.HCl, 1mg/ml in Methanol (as free base); SR-01000075541-1; SR-01000075541-3; SR-01000075541-7; Q27105997; Z1541759502; Buspirone Hydrochloride 1.0 mg/ml in Methanol (as free base); Buspirone hydrochloride, European Pharmacopoeia (EP) Reference Standard; Buspirone hydrochloride, United States Pharmacopeia (USP) Reference Standard; 8-[4-(4-pyrimidin-2-ylpiperazinyl)butyl]-8-azaspiro[4.5]decane-7,9-dione, chlo ride; 8-Azaspiro[4.5]decane-7, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride; Buspirone for system suitability, European Pharmacopoeia (EP) Reference Standard; Buspirone hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; 1-[4-(7,9-dioxo-8-azaspiro[4.5]decan-8-yl)butyl]-4-(pyrimidin-2-yl)piperazin-1-ium chloride; 8-[4-[4-(2-Pyrimidinyl)-1-pipirazin yl]butyl]-8-azaspiro[4,5]decane-7,9-dione hydrochloride; 8-[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]-decane-7,9-dione hydrochloride; 8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione hydrochloride; 8-{4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione--hydrogen chloride (1/1); 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, hydrochloride (1:1)Synonyms
Products Containing Buspirone Hydrochloride
영진부스피론정10밀리그램(부스피론염산염)영진부스피론정5밀리그램(부스피론염산염)파마부스피론정5밀리그램(부스피론염산염)파마부스피론정10밀리그램(부스피론염산염)부포닌정10밀리그램(부스피론염산염)부포닌정5밀리그램(부스피론염산염)바브론정5mg(부스피론염산염)바브론정10mg(부스피론염산염)환인부스피론정10밀리그램(부스피론염산염)환인부스피론정5밀리그램(부스피론염산염)부스포론정5mg(부스피론염산염)부스핀정5mg(부스피론염산염)
Page 1 of 3
Companies Selling Buspirone Hydrochloride
(주
(주)보령Republic of Korea환인
환인제약(주)Republic of Korea영진
영진약품(주)Republic of Korea부광
부광약품(주)Republic of Korea진양
진양제약(주)Republic of Korea(주
(주)씨티씨바이오Republic of KoreaJN
Jiangsu Nhwa Pharmaceutical Co., Ltd.ChinaTQ
Taicang Qianjing Chemical Co., Ltd.ChinaVS
VIATRIS SANTEFranceSA
SANDOZFrance하나
하나제약(주)Republic of KoreaPage 1 of 2